Literature DB >> 14516133

Do GOLD stages of COPD severity really correspond to differences in health status?

R Antonelli-Incalzi1, C Imperiale, V Bellia, F Catalano, N Scichilone, R Pistelli, F Rengo.   

Abstract

The purpose of this study was to assess whether different stages of chronic obstructive pulmonary disease (COPD) severity defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria correlate with meaningful differences in health status. A total of 381 COPD patients, aged 73+/-6 yrs, were classified in the five GOLD stages. Disease-specific (St George Respiratory Questionnaire (SGRQ)) and generic indexes of health status were measured in all patients. Multivariate analysis of covariance or Kruskal Wallis tests were used to compare health status indexes across the spectrum of GOLD stages of COPD severity. GOLD stages of COPD severity significantly differed in SGRQ components and Barthel's index, but not in the indexes assessing cognitive and affective status and quality of sleep. The largest variation in health status was observed at the transition from stage IIa to stage IIb, while there were no other significant differences between consecutive stages. Both female sex and comorbidity were associated with a greater impact of COPD on the health status. In conclusion, the upper limit of stage IIb (forced expiratory volume in one second of 49%) marks a threshold for dramatic worsening of health status. Progression of chronic obstructive pulmonary disease severity from stage 0 to stage IIa does not correspond to any meaningful difference in health status.

Entities:  

Mesh:

Year:  2003        PMID: 14516133     DOI: 10.1183/09031936.03.00101203

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  42 in total

Review 1.  Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; M Rutten-Van Mölken; J Buffels; O Van Schayck; P-A Gevenois; R Pellegrino; E Derom; W De Backer
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

2.  Low-dose multislice CT and high-resolution CT assessment of pulmonary emphysema in public school teachers.

Authors:  Noriaki Horiuchi; Jiro Fujita; Ichizo Suemitsu; Yasuhiro Yamasaki; Futoshi Higa; Masao Tateyama
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

3.  Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D.

Authors:  Ji Young Hong; Song Yee Kim; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Ae Kang; Se Kyu Kim; Joon Chang; Young Sam Kim
Journal:  Qual Life Res       Date:  2015-04-05       Impact factor: 4.147

4.  Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation.

Authors:  C van de Bool; C Mattijssen-Verdonschot; P P M J van Melick; M A Spruit; F M E Franssen; E F M Wouters; A M W J Schols; E P A Rutten
Journal:  Eur J Clin Nutr       Date:  2013-12-11       Impact factor: 4.016

Review 5.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

6.  Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?

Authors:  Kian-Chung Ong; Suat-Jin Lu; Cindy Seok-Chin Soh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 7.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

8.  Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification.

Authors:  Tewe L Verhage; Yvonne F Heijdra; Johan Molema; Leonie Daudey; P N Richard Dekhuijzen; Jan H Vercoulen
Journal:  Open Respir Med J       Date:  2009-02-13

9.  Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry.

Authors:  Sheng-Hsiang Lin; Ping-Hung Kuo; Sow-Hsong Kuo; Pan-Chyr Yang
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

10.  Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients.

Authors:  Negro Roberto Dal; M Eandi; L Pradelli; S Iannazzo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.